DK0683167T3 - Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling - Google Patents

Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling

Info

Publication number: DK0683167T3
Authority: DK; Denmark
Prior art keywords: preparation; methods; terazosin monohydrochloride; intermediates; terazosin
Prior art date: 1994-05-20

Application number

DK95103186T

Other languages

English (en)

Inventor

James A Morley

John F Bauer

Ramesh R Patel

Stephen G Spanton

Rodger F Henry

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-20

Filing date

1995-03-06

Publication date

2000-02-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22931058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0683167(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-06 Application filed by Abbott Lab filed Critical Abbott Lab

2000-02-07 Application granted granted Critical

2000-02-07 Publication of DK0683167T3 publication Critical patent/DK0683167T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK95103186T 1994-05-20 1995-03-06 Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling DK0683167T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/246,526 US5412095A (en)	1993-04-29	1994-05-20	Terazosin monohydrochloride and processes and intermediate for its production

Publications (1)

Publication Number	Publication Date
DK0683167T3 true DK0683167T3 (da)	2000-02-07

Family

ID=22931058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95103186T DK0683167T3 (da)	1994-05-20	1995-03-06	Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling

Country Status (9)

Country	Link
US (1)	US5412095A (da)
EP (1)	EP0683167B1 (da)
JP (1)	JP2755918B2 (da)
AT (1)	ATE182592T1 (da)
CA (1)	CA2143974C (da)
DE (2)	DE683167T1 (da)
DK (1)	DK0683167T3 (da)
ES (1)	ES2093579T3 (da)
GR (2)	GR960300046T1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5587377A (en) *	1995-10-24	1996-12-24	Invamed, Inc.	Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) *	1995-12-13	1997-06-19	Uetikon Chemie Gmbh	Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) *	1996-08-01	1999-09-14	Novartis Corporation	Terazosin capsules
IT1286789B1 (it) *	1996-11-29	1998-07-17	Alfa Chem Ital	Processo per la produzione della forma i del terazosin monocloridato anidro
IT1286790B1 (it) *	1996-11-29	1998-07-17	Alfa Chem Ital	Processo per la produzione della forma i del terazosin monocloridrato anidro
EP0849265A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von Doxazosin-Mesylat (Form II)
ES2282997T3 (es) *	1996-12-20	2007-10-16	Heumann Pcs Gmbh	Nueva forma polimorfa de mesilato e doxazosina (forma iii).
EP0849264A1 (de) *	1996-12-20	1998-06-24	HEUMANN PHARMA GmbH	Neue polymorphe Form von doxazosinmesylat (Form I)
US6248888B1 (en)	1997-11-14	2001-06-19	Teva Pharmaceutical Industries Ltd.	Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en)	1999-12-03	2001-03-13	Starcor Pharmaceuticals, Inc.	Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20030068829A1 (en) *	2001-06-25	2003-04-10	Symyx Technologies, Inc.	High throughput crystallographic screening of materials
TWI353979B (en) *	2002-04-10	2011-12-11	Nippon Zoki Pharmaceutical Co	Novel crystal form of 5-hydroxy-1-methylhydantoin
US20080039473A1 (en) *	2006-08-08	2008-02-14	Auspex Pharmaceuticals, Inc.	Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4026894A (en) *	1975-10-14	1977-05-31	Abbott Laboratories	Antihypertensive agents
GB1591490A (en) *	1977-08-04	1981-06-24	Abbott Lab	1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
ATE72244T1 (de) *	1986-03-21	1992-02-15	Heumann Pharma Gmbh & Co	Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5212176A (en) *	1990-06-29	1993-05-18	Abbott Laboratories	R(+)-terazosin
JP2652272B2 (ja) *	1990-12-31	1997-09-10	住化ファインケム株式会社	１−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) *	1993-04-29	1994-03-15	Abbott Laboratories	Terazosin polymorph and pharmaceutical composition

1994
- 1994-05-20 US US08/246,526 patent/US5412095A/en not_active Expired - Fee Related
1995
- 1995-03-06 DE DE0683167T patent/DE683167T1/de active Pending
- 1995-03-06 DE DE69510999T patent/DE69510999T2/de not_active Expired - Fee Related
- 1995-03-06 ES ES95103186T patent/ES2093579T3/es not_active Expired - Lifetime
- 1995-03-06 AT AT95103186T patent/ATE182592T1/de not_active IP Right Cessation
- 1995-03-06 DK DK95103186T patent/DK0683167T3/da active
- 1995-03-06 EP EP95103186A patent/EP0683167B1/en not_active Expired - Lifetime
- 1995-03-06 CA CA002143974A patent/CA2143974C/en not_active Expired - Fee Related
- 1995-03-15 JP JP7055912A patent/JP2755918B2/ja not_active Expired - Lifetime
1996
- 1996-08-31 GR GR960300046T patent/GR960300046T1/el unknown
1999
- 1999-09-16 GR GR990402341T patent/GR3031248T3/el unknown

Also Published As

Publication number	Publication date
HK1012629A1 (en)	1999-08-06
GR960300046T1 (en)	1996-08-31
US5412095A (en)	1995-05-02
ES2093579T1 (es)	1997-01-01
EP0683167A1 (en)	1995-11-22
CA2143974A1 (en)	1995-11-21
CA2143974C (en)	1997-06-03
DE683167T1 (de)	1996-11-07
DE69510999T2 (de)	2000-02-17
ES2093579T3 (es)	1999-11-01
JPH0848685A (ja)	1996-02-20
DE69510999D1 (de)	1999-09-02
GR3031248T3 (en)	1999-12-31
EP0683167B1 (en)	1999-07-28
ATE182592T1 (de)	1999-08-15
JP2755918B2 (ja)	1998-05-25

Publication	Publication Date	Title
DK0683167T3 (da)	2000-02-07	Terazosin monohydrochlorid og fremgangsmåder og mellemprodukter til dets fremstilling
NO932870D0 (no)	1993-08-12	Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
HU9601857D0 (en)	1996-08-28	New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
ES2162367T3 (es)	2001-12-16	Metodo de produccion de un compuesto de aminobenceno.
MXPA04000847A (es)	2004-03-26	Procedimiento para la obtencion de beraprost y sus sales.
DE3851865D1 (de)	1994-11-24	Verfahren zur Umwandlung des niedrigschmelzenden Polymorphs von Buspirone hydrochlorid in das höherschmelzende.
DK0543095T3 (da)	1999-09-13	Fremgangsmåde til fremstilling af 2-amino-6-halogenpurin og syntese af et mellemprodukt dertil
FR2557876B1 (fr)	1991-04-19	Synthese a haute pression de melamine anhydre
DE3572969D1 (en)	1989-10-19	A novel process for the preparation of bestatin derivatives and intermediates thereof
FI951212A7 (fi)	1995-03-15	beta-metyylikarbapeneemivälituotteiden valmistus
DK0492350T3 (da)	1998-01-26	Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
NO861953L (no)	1986-11-18	Oksadiazolylimidazobenzodiazepinforbindelse og fremgangsmaate til fremstilling derav.
DK0506235T3 (da)	1999-10-25	Glyceraldehyd-3-pentanid og fremgangsmåde til fremstilling af samme
NO306155B1 (no)	1999-09-27	Nye fremgangsmÕter for fremstilling av (S)-4-amino-hepta-5,6-diensyre og mellomprodukter derav
FI952142L (fi)	1995-11-06	Parannettu suurtuotantomenetelmä atsapironin synteesiä varten
FI933423A7 (fi)	1993-07-30	ACAT-inhibiittorien valmistuksen välituotteiden synteesi
WO2001092251A3 (en)	2003-04-17	Aryloxy ester and acid compounds
HU0000823D0 (en)	2000-04-28	Process for producing intermediates, which applicable at production of n-(aryl-oxy-alkyl)-heteroaryl-piperidine-and heteroaryl-piperazine derivatives